Literature DB >> 27900801

GSK-3: A key regulatory target for ketamine's rapid antidepressant effects mediated by enhanced AMPA to NMDA throughput.

Carlos A Zarate1, Rodrigo Machado-Vieira1.   

Abstract

Entities:  

Keywords:  glycogen synthase kinase 3 (GSK-3); ketamine; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)

Mesh：

Substances：

Year:  2016        PMID： 27900801      PMCID： PMC5222739          DOI： 10.1111/bdi.12452

Source DB:  PubMed          Journal:  Bipolar Disord        ISSN： 1398-5647            Impact factor:   6.744


× No keyword cloud information.
  32 in total

1.  Synaptic strength regulated by palmitate cycling on PSD-95.

Authors:  Alaa El-Din El-Husseini; Eric Schnell; Srikanth Dakoji; Neal Sweeney; Qiang Zhou; Oliver Prange; Catherine Gauthier-Campbell; Andrea Aguilera-Moreno; Roger A Nicoll; David S Bredt
Journal:  Cell       Date:  2002-03-22       Impact factor: 41.582

Review 2.  New targets for rapid antidepressant action.

Authors:  Rodrigo Machado-Vieira; Ioline D Henter; Carlos A Zarate
Journal:  Prog Neurobiol       Date:  2015-12-23       Impact factor: 11.685

3.  Inhibition of glycogen synthase kinase-3 is necessary for the rapid antidepressant effect of ketamine in mice.

Authors:  E Beurel; L Song; R S Jope
Journal:  Mol Psychiatry       Date:  2011-04-19       Impact factor: 15.992

Review 4.  Synaptic mechanisms underlying rapid antidepressant action of ketamine.

Authors:  Ege T Kavalali; Lisa M Monteggia
Journal:  Am J Psychiatry       Date:  2012-11       Impact factor: 18.112

5.  Acute increases in plasma mammalian target of rapamycin, glycogen synthase kinase-3β, and eukaryotic elongation factor 2 phosphorylation after ketamine treatment in three depressed patients.

Authors:  Chun Yang; Zhi-qiang Zhou; Zhi-qin Gao; Jin-yun Shi; Jian-Jun Yang
Journal:  Biol Psychiatry       Date:  2012-08-09       Impact factor: 13.382

Review 6.  Ketamine and the next generation of antidepressants with a rapid onset of action.

Authors:  Rodrigo Machado-Vieira; Giacomo Salvadore; Nancy Diazgranados; Carlos A Zarate
Journal:  Pharmacol Ther       Date:  2009-05-03       Impact factor: 12.310

7.  Ketamine-like effects of a combination of olanzapine and fluoxetine on AMPA and NMDA receptor-mediated transmission in the medial prefrontal cortex of the rat.

Authors:  Carl Björkholm; Kent Jardemark; Björn Schilström; Torgny H Svensson
Journal:  Eur Neuropsychopharmacol       Date:  2015-07-20       Impact factor: 4.600

8.  Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors.

Authors:  Sungho Maeng; Carlos A Zarate; Jing Du; Robert J Schloesser; Joseph McCammon; Guang Chen; Husseini K Manji
Journal:  Biol Psychiatry       Date:  2007-07-23       Impact factor: 13.382

9.  Glycogen synthase kinase-3 in the etiology and treatment of mood disorders.

Authors:  Richard Scott Jope
Journal:  Front Mol Neurosci       Date:  2011-08-09       Impact factor: 5.639

10.  A pivotal role of GSK-3 in synaptic plasticity.

Authors:  Clarrisa A Bradley; Stéphane Peineau; Changiz Taghibiglou; Celine S Nicolas; Daniel J Whitcomb; Zuner A Bortolotto; Bong-Kiun Kaang; Kwangwook Cho; Yu Tian Wang; Graham L Collingridge
Journal:  Front Mol Neurosci       Date:  2012-02-15       Impact factor: 5.639
View more
  7 in total

Review 1.  Ketamine and Beyond: Investigations into the Potential of Glutamatergic Agents to Treat Depression.

Authors:  Marc S Lener; Bashkim Kadriu; Carlos A Zarate
Journal:  Drugs       Date:  2017-03       Impact factor: 9.546

2.  The Mechanisms Behind Rapid Antidepressant Effects of Ketamine: A Systematic Review With a Focus on Molecular Neuroplasticity.

Authors:  Melody J Y Kang; Emily Hawken; Gustavo Hector Vazquez
Journal:  Front Psychiatry       Date:  2022-04-25       Impact factor: 5.435

3.  Brief isoflurane anesthesia regulates striatal AKT-GSK3β signaling and ameliorates motor deficits in a rat model of early-stage Parkinson's disease.

Authors:  Juuso V Leikas; Samuel Kohtala; Wiebke Theilmann; Aaro J Jalkanen; Markus M Forsberg; Tomi Rantamäki
Journal:  J Neurochem       Date:  2017-06-14       Impact factor: 5.372

4.  Rapid and long-lasting antidepressant-like effects of ketamine and their relationship with the expression of brain enzymes, BDNF, and astrocytes.

Authors:  G S B Viana; E M do Vale; A R A de Araujo; N C Coelho; S M Andrade; R O da Costa; P E A de Aquino; C N S de Sousa; I S de Medeiros; S M M de Vasconcelos; K R T Neves
Journal:  Braz J Med Biol Res       Date:  2020-12-18       Impact factor: 2.590

Review 5.  The Ketamine Antidepressant Story: New Insights.

Authors:  Tahani K Alshammari
Journal:  Molecules       Date:  2020-12-07       Impact factor: 4.411

Review 6.  Eradicating Suicide at Its Roots: Preclinical Bases and Clinical Evidence of the Efficacy of Ketamine in the Treatment of Suicidal Behaviors.

Authors:  Domenico De Berardis; Michele Fornaro; Alessandro Valchera; Marilde Cavuto; Giampaolo Perna; Marco Di Nicola; Gianluca Serafini; Alessandro Carano; Maurizio Pompili; Federica Vellante; Laura Orsolini; Annastasia Fiengo; Antonio Ventriglio; Kim Yong-Ku; Giovanni Martinotti; Massimo Di Giannantonio; Carmine Tomasetti
Journal:  Int J Mol Sci       Date:  2018-09-23       Impact factor: 5.923

7.  Repeated but Not Single Administration of Ketamine Prolongs Increases of the Firing Activity of Norepinephrine and Dopamine Neurons.

Authors:  Chidiebere M Iro; Rami Hamati; Mostafa El Mansari; Pierre Blier
Journal:  Int J Neuropsychopharmacol       Date:  2021-07-23       Impact factor: 5.176
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.